14 August 2018 in Russian Journal of Cardiology
Aim.Comparison of in-hospital results of two strategies on an aimed incomplete myocardial revascularization (AIMR) ONCAB and MIDCAB of left anterior descending artery (LAD) in multivessel coronary disease patients.Material and methods.To the study, 63 patients included with achieved AIMR (LAD shunting) in multivessel disease. All patients, depending on the strategy of revascularization, were selected to 2 groups: 1. ONCAB (47,6%, n=30) and 2. MIDCAB (52,4%, n=33).Results.In the early post-surgery period of follow-up, among the adverse cardiovascular events, in the general selection of patients, there was non-fatal Q-myocardial infarction in MIDCAB group, followed by a decline of the left ventricle ejection fraction from 65% to 38%. ONCAB group was characterized by higher volume intra-operational blood loss, rate of wound and hemorrhagic complications, that in one case led to remediastinotomy, and in every tenth patient — blood transfusion during the early period. In our study, the chosen surgical strategy was the only alternative to medication therapy.Conclusion.In the study, at in-hospital stage of management there were comparable outcomes of AIMR with either ONCAB and MIDCAB. Nevertheless, coronary bypass with MIDCAB technology demonstrated a range of benefits related to decreased risk of hemorrhagic complications, wound infection and lower duration of hospitalization.
25 March 2020 in Complex Issues of Cardiovascular Diseases
Aim To evaluate in-hospital and long-term outcomes of myocardial and cerebral revascularization with combined or staged PCI and carotid endarterectomy.Methods.263 myocardial and cerebral revascularizations with PCI and CEA in patients with combined cerebral and coronary artery lesions in the period from 2011 to 2017 were performed. Patients were divided into two groups depending on the surgical strategy. Patient (n = 133) who underwent a staged intervention (CEA and PCI) were included in Group 1, whereas patients (n = 130) who underwent a hybrid intervention (CEE+PCI CA) were included in Group 2. The mean follow-up was 3.5 years.Results.100% of patients in Group 2 underwent coronary and internal carotid revascularization according to the results of in-hospital and long-term follow-up. 81.35% of patient in Group 1 underwent PCI and CEA, whereas 3.01% of patients underwent only PCI and 6.77% of patients – CEA. 1.5% of patients in Group 1 did not receive any surgical treatment. The most common causes of incomplete revascularization were the subsequent change of the initially defined treatment for myocardial (6.02%) or cerebral revascularization (0.75%). The rest refused the second stage, or it was associated with extremely high risk and the strategy was switched to the conservative therapy.Conclusion.100% of patients received hybrid myocardial and cerebral revascularization during one hospitalization. It allowed reducing mortality from MI and stroke during the waiting period for the next stage of the treatment in Group 1 (almost 5%). Hybrid interventions can be used in patients with high risk for open-heart surgery, severe comorbidities (obesity, diabetes, renal dysfunction), significant coronary and cerebral artery lesions with high risk of MI and stroke. However, hybrid approach was associated with high rate (almost 7%) of non-fatal MI in the long-term follow-up.
27 December 2019 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Among cardiovascular diseases, multifocal atherosclerosis has begun occurring more frequently in the recent years; its manifestations such as coronary heart disease and acute cerebrovascular disease are the primary cause of death and disability worldwide. Both open and endovascular methods of surgical revascularisation of the brain and myocardium are presently used for addressing this global epidemic. Therefore, the outcomes and disease course during both the early postoperative and long-term periods in patients with multifocal atherosclerosis depend on the choice of appropriate surgical strategies. However, there is no consensus on the optimal strategies for the combined treatment of lesions in the coronary and cerebral basins. Consequently, there are no clinical recommendations or randomised trials that provide recommendations on the choice of treatment approaches in this cohort of patients. The specific treatment options are based on the personal experience of the clinic and the decision of the multidisciplinary team.Nevertheless, it is certain that carotid endarterectomy remains the gold standard for the treatment of significant stenosis of internal carotid artery, including that with complex anatomical characteristics and severe calcification; carotid endarterectomy is also the most important preventative measure for the acute violation of cerebral circulation. In addition, given the emergence of new coronary stents and the spread of intravascular imaging methods, percutaneous coronary intervention is increasing its evidence base by the year by demonstrating efficacy even in patients with concomitant left coronary artery trunk and multi-vascular coronary bed lesions.The use of carotid endarterectomy in combination with percutaneous coronary intervention in patients with lesions in both vascular basins for achieving hybrid revascularisation is promising although studied minimally.Therefore, in the present review, we aimed to present the current understanding of the methods utilised for revascularisation of the brain and myocardium as well as the hybrid revascularisation approach for the treatment of patients with multifocal atherosclerosis, with consideration given to its advantages and prospects.Received 12 April 2019. Revised 17 December 2019. Accepted 24 December 2019.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.
6 January 2023 in Cardiovascular Therapy and Prevention
Aim. To analyze factors affecting the availability of hybrid cerebral and myocardial revascularization by synchronous percutaneous coronary intervention (PCI) and carotid endarterectomy (CEA).Material and methods. This retrospective study included 263 patients with coronary and internal carotid artery involvement undergoing PCI and CEA during the period from 2011 to 2017.Results. The study revealed the following factors increasing the availability of revascularization: hybrid cerebral and myocardial revascularization, successful PCI using drug-eluting stents, postPCI TIMI flow grade 3, and radial access for PCI. The following factors reduced the availability: polyvascular disease >50% in three beds, prior PCI, left ventricular ejection fraction 9, emergency hospitalization and multiple emergency PCI of the coronary arteries in the long-term follow-up period.Conclusion. Comprehensive analysis of clinical, demographic, anatomical, angiographic, and perioperative factors made it possible to identify predictors that affect the availability of hybrid revascularization.
4 May 2026 in Complex Issues of Cardiovascular Diseases
Highlights Various methods of over-frequency ventricular stimulation in endovascular interventions on heart valves are analyzed. A new method of pacing using an over-stiff guidewire in the left ventricle and a coronary guidewire in the femoral artery is presented in transcatheter aortic valve replacement . Absract The publication presents and substantiates the methodology of pacing in TIAC using an ultra-rigid conductor in the left ventricle and a coronary conductor in the femoral artery. A technique for ultra–frequent stimulation of the ventricles of the heart is described, in particular, the use of a coronary artery in the femoral artery, the approach is illustrated by a clinical example. The proposed method makes it possible to successfully perform transcatheter intervention on the aortic valve: it provides stable, ultra-frequent stimulation of the ventricles at small amplitudes, while it does not require additional manipulations, new accesses, special tools and additional material costs.
27 May 2026 in Russian Journal of Cardiology and Cardiovascular Surgery
Objective. To analyze the annual results after percutaneous mitral valve repair using edge-to-edge mitral valve coaptation device in patients from the waiting list for heart transplantation. Material and methods. In July 2023, 4 patients underwent percutaneous mitral valve repair with edge-to-edge mitral valve coaptation device for severe mitral regurgitation. Open surgery was refused due to high risk and complicated cardiac diseases (reduced ejection fraction, left ventricular aneurysm, severely decreased left ventricular contractility, pulmonary hypertension, previous cardiac surgeries), and transcatheter intervention was preferred. All patients underwent echocardiography before the intervention, at discharge and one year after correction of mitral regurgitation. Drug therapy, heart failure and adverse cardiovascular events were assessed. Results. All patients were followed-up by a cardiologist and took the prescribed therapy. No significant adverse cardiovascular events were registered throughout the follow-up period. All patients took therapy including diuretics, β-blockers, ACE inhibitors, angiotensin II receptor antagonists, and statins. In long-term follow-up, all patients showed decrease in ejection fraction. In 75% of cases, LV EDV/ESV and pulmonary artery pressure increased compared to in-hospital data. In 3 (75%) patients, mitral insufficiency returned to baseline values after a year. Conclusion. Undoubtedly, percutaneous edge-to-edge mitral valve repair is a fairly promising procedure and provides a chance for favorable outcomes in high-risk patients. This approach can also justify percutaneous intervention as a «bridge» to heart transplantation. However, contradictory data of various studies necessitate further research and accumulation of experience. Therefore, larger samples of patients and analysis of long-term postoperative results will allow us to obtain new knowledge about dynamics of clinical status in patients with CHF and MR, cardiac remodeling and selection criteria for such interventions.